Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Results 1 - 20 of 70 : 1 2 3 4 Next »

Recs

0
Member Avatar ChemEngChap (38.59) Submitted: 1/15/2015 8:50:08 AM : Outperform Start Price: $13.39 KERX Score: -30.20

This is my WAG: after struggling for so many years I would have preferred the company being sold to a big pharma and cash in quickly, but what the heck! After having seen roughly 90% of my investment being wiped out only to see 300% upside a few years later I might as well remain on this one until the end - can't say this ride is mildly emotional, though.

I admit my argument is more emotional than analytical. Just as with any other small biotech out there, anything could happen and analysis are of relative importance. In this case KERX is launching its first product after struggling for over a decade, so I'm starting to see the light at the end of the tunnel.

However, running a working pharma is very different than enticing investors on the promise of a golden future (this is why I would have rather preferred the company being sold to a big pharma), so KERX still has a lot to prove, though.

People with delicate nerves please abstain.

Recs

0
Member Avatar keelfoot (< 20) Submitted: 6/26/2014 11:20:30 AM : Outperform Start Price: $15.55 KERX Score: -43.89

Getting close to success with key much needed diabetes drugs.

Recs

0
Member Avatar 78taxs (< 20) Submitted: 6/24/2014 12:08:55 PM : Outperform Start Price: $15.49 KERX Score: -42.82

treatment for diabetes

Recs

0
Member Avatar chitownatiiive (< 20) Submitted: 1/30/2014 8:08:49 PM : Outperform Start Price: $15.51 KERX Score: -54.41

i feel it. im brand at trying ive attempted to study the market but have been lazy this is a lucky guess based on how its already moving upward and is rated 80% bullish

Recs

0
Member Avatar Litigation (22.18) Submitted: 3/16/2013 7:15:33 PM : Outperform Start Price: $7.25 KERX Score: -0.21

Price Target: $13

Recs

0
Member Avatar scrubs62074 (51.71) Submitted: 1/23/2013 2:03:57 PM : Outperform Start Price: $3.81 KERX Score: +116.29

High volume breakout 1/23/13

Recs

0
Member Avatar NHWeston102 (62.83) Submitted: 7/6/2012 10:13:26 PM : Outperform Start Price: $1.93 KERX Score: +350.54

Outclassed in all its categories but a fair buy-out candidates.

Recs

0
Member Avatar Robase06 (< 20) Submitted: 5/23/2012 10:12:36 PM : Outperform Start Price: $1.78 KERX Score: +389.81

Zerenex

Recs

0
Member Avatar TXKL (< 20) Submitted: 5/16/2012 4:05:00 PM : Outperform Start Price: $1.85 KERX Score: +369.41

Big buyout rumors.

Recs

0
Member Avatar someboy0808 (< 20) Submitted: 5/11/2012 6:47:34 PM : Outperform Start Price: $1.98 KERX Score: +336.60

Top line Positive phase 3 drug report from Japan, and 100million license fee, you know this company is not going down any time soon!

Recs

0
Member Avatar wcaddict (< 20) Submitted: 4/23/2012 12:10:52 PM : Outperform Start Price: $1.71 KERX Score: +416.84

news

Recs

0
Member Avatar Stef100000 (< 20) Submitted: 4/10/2012 1:22:13 PM : Underperform Start Price: $1.42 KERX Score: -532.32

No future

Recs

0
Member Avatar solanZRaider (< 20) Submitted: 4/2/2012 5:36:17 PM : Outperform Start Price: $1.69 KERX Score: +428.83

bravo

Recs

0
Member Avatar WRXkid (84.54) Submitted: 3/29/2012 2:01:49 PM : Outperform Start Price: $4.83 KERX Score: +52.64

Possible positive outcome of clinical trials for perifosine.

Recs

0
Member Avatar saulucy20 (< 20) Submitted: 3/16/2012 6:02:54 AM : Outperform Start Price: $4.18 KERX Score: +84.88

Phase 3 on Perifosine

Recs

0
Member Avatar RBuskey106 (68.78) Submitted: 3/14/2012 10:42:20 PM : Outperform Start Price: $4.10 KERX Score: +89.16

Betting on perifosine for the short term bump

Recs

0
Member Avatar KimLanners (< 20) Submitted: 10/14/2011 1:51:20 PM : Outperform Start Price: $2.79 KERX Score: +178.38

biotech

Recs

0
Member Avatar vaderblue (< 20) Submitted: 8/31/2011 5:00:26 PM : Outperform Start Price: $4.11 KERX Score: +67.02

I am an investor of Kerx for along time. I am hinting this is a must deal for them. Good news today but like
having babies, we must wait it out.

Recs

0
Member Avatar bikesncats (< 20) Submitted: 7/15/2011 4:25:23 AM : Outperform Start Price: $4.92 KERX Score: +40.15

Phase 3 trials will show if this "lottery ticket" has what is takes to become a 10 bagger, I believe so.

Recs

0
Member Avatar almostgem (46.38) Submitted: 6/9/2011 2:51:10 PM : Outperform Start Price: $4.83 KERX Score: +41.67

See Aezs - This company has exclusive rights to market a cancer drug that is now in stage III trials. If successful, both companies should soar !

Results 1 - 20 of 70 : 1 2 3 4 Next »

Featured Broker Partners


Advertisement